Stay updated on Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page.

Latest updates to the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s displayed software/browser revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than changes to the clinical trial record.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check57 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision: v3.4.2 was added. The previous funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.5%

- Check100 days agoChange DetectedDifference0.5%

Stay in the know with updates to Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page.